Oruka Therapeutics Inc (NASDAQ:ORKA)’s traded shares stood at 0.47 million during the last session, with the company’s beta value hitting 0.40. At the close of trading, the stock’s price was $7.68, to imply an increase of 4.21% or $0.31 in intraday trading. The ORKA share’s 52-week high remains $33.00, putting it -329.69% down since that peak but still an impressive 28.52% since price per share fell to its 52-week low of $5.49. The company has a valuation of $287.55M, with an average of 0.58 million shares in intraday trading volume over the past 10 days and average of 312.34K shares over the past 3 months.
Oruka Therapeutics Inc (NASDAQ:ORKA) trade information
After registering a 4.21% upside in the last session, Oruka Therapeutics Inc (ORKA) has traded red over the past five days. The 5-day price performance for the stock is -1.92%, and -31.06% over 30 days. With these gigs, the year-to-date price performance is -60.39%. Short interest in Oruka Therapeutics Inc (NASDAQ:ORKA) saw shorts transact 1.55 million shares and set a 6.72 days time to cover.
The extremes give us $20 and $20 for target low and target high price respectively. As such, ORKA has been trading -160.42% off suggested target high and -160.42% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 36.88% for the past 5-year period. While 2025 is set for a 39.53% return in earnings, projections for the next 5 years are at 16.79% annually.
ORKA Dividends
Oruka Therapeutics Inc has its next earnings report out on 2025-Mar-05. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Oruka Therapeutics Inc (NASDAQ:ORKA)’s Major holders
Oruka Therapeutics Inc insiders hold 3.25% of total outstanding shares, with institutional holders owning 85.78% of the shares at 88.66% float percentage. In total, 85.78% institutions holds shares in the company.
We also have T. Rowe Price Health Sciences Fund, Inc. and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Oruka Therapeutics Inc (ORKA) shares. Going by data provided on Dec 31, 2024 , T. Rowe Price Health Sciences Fund, Inc. holds roughly 1.11 shares. This is just over 2.98% of the total shares, with a market valuation of $8.56 million. Data from the same date shows that the other fund manager holds a little less at 1.09, or 2.90% of the shares, all valued at about 8.34 million.
